Contraception system and method

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4921843
SERIAL NO

07260447

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of contraception is disclosed which comprises a two-stage protocol. In the first stage, an estrogenic compound in a first composition is administered daily as the sole contraceptively active substance to a human female from about Day 2 to about Day 7 of her menstrual cycle, where Day 1 is the first day of menses. The second stage of the protocol occurs immediately thereafter during which at least one follow-up composition containing a progestin is administered daily to the same human female. The follow-up composition can contain a progestin as the sole contraceptively active ingredient, or can contain a combination of an estrogenic compound with a progestin in different weight ratios. A drug delivery system containing daily dosage units is also described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GYNEX PHARMACEUTICALS INC A NV CORPORATION1175 CORPORATE WOODS PARKWAY VERNON HILLS IL 60061

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pasquale, Samuel A 5 Normandy Ct., Basking Ridge, NJ 07920 6 223

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation